Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

被引:13
|
作者
Terai, Mizue [1 ]
Shimada, Ayako [2 ]
Chervoneva, Inna [2 ]
Hulse, Liam [1 ]
Danielson, Meggie [1 ]
Swensen, Jeff [3 ]
Orloff, Marlana [1 ]
Wedegaertner, Philip B. [4 ]
Benovic, Jeffrey L. [4 ]
Aplin, Andrew E. [5 ]
Sato, Takami [1 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[3] Caris Life Sci, Mol Genet, Phoenix, AZ 85040 USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
uveal melanoma; metastasis; metastatic uveal melanoma; survival; GNA11; GNAQ; Q209P; Q209L; BAP1; SF3B1; ONCOGENIC MUTATIONS; GNAQ; SURVIVAL;
D O I
10.3390/cancers13225749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. More than 90% of UMs harbor mutually exclusive activating mutations in G-proteins. The mutations are early events in UM development and considered to be driver mutations in carcinogenesis. Even after treatment of primary uveal melanoma, up to 50% of patients subsequently develop recurrence, predominantly in the liver. GNAQ mutations are not reported to be correlated to survival, while the mutations in GNA11 are reported more frequently in metastatic UM. We investigated the correlation of survival after development of metastasis (Met-to-Death) of metastatic uveal melanoma (MUM) patients with GNA11 and GNAQ mutations. We identified that MUM with mutation patterns of Q209P vs. Q209L in GNA11 and GNAQ might predict survival of MUM patients. Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (GNAQ) and G protein subunit alpha 11 (GNA11). Although they are considered to be driver mutations, their role in MUM remains elusive. We investigated key somatic mutations ofMUM and their impact on patients' survival after development of systemic metastasis (Met-to-Death). Metastatic lesions from 87 MUM patients were analyzed by next generation sequencing (NGS). GNA11 (41/87) and GNAQ (39/87) mutations were most predominantly seen in MUM. Most GNA11 mutations were Q209L (36/41), whereas GNAQ mutations comprised Q209L (14/39) and Q209P (21/39). Epigenetic pathway mutations BAP1 (42/66), SF3B1 (11/66), FBXW7 (2/87), PBRM1 (1/66), and SETD2 (1/66) were found. No specimen had the EIF1AX mutation. Interestingly, Met-to-Death was longer in patients with GNAQ Q209P compared to GNAQ/GNA11 Q209L mutations, suggesting the difference in mutation type in GNAQ/GNA11 might determine the prognosis of MUM. Structural alterations of the GNAQ/GNA11 protein and their impact on survival of MUM patients should be further investigated.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations
    Yavuzyigitoglu, Serdar
    Mensink, Hanneke W.
    Smit, Kyra N.
    Vaarwater, Jolanda
    Verdijk, Robert M.
    Beverloo, Berna
    Bruggenwirth, Hennie T.
    van Marion, Ronald
    Dubbink, Hendrikus J.
    Paridaens, Dion
    Naus, Nicole C.
    de Klein, Annelies
    Kilic, Emine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (04) : 2232 - 2239
  • [42] Metastatic patterns in posterior uveal melanoma
    Hindso, Tine Gadegaard Gadegaard
    Madsen, Karine
    Bjerrum, Camilla Wium
    Faber, Carsten
    Nissen, Kristoffer
    Heegaard, Steffen
    Bagger, Mette
    Kiilgaard, Jens F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma
    Zhao, Andi
    Wang, Zijin
    Wang, Yue
    Chen, Xuejuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (05): : 3131 - +
  • [44] Metastatic uveal melanoma: The final frontier
    Rantala, Elina S.
    Hernberg, Micaela M.
    Piperno-Neumann, Sophie
    Grossniklaus, Hans E.
    Kivela, Tero T.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2022, 90
  • [45] New markers for metastatic uveal melanoma
    Pe'er, J.
    Folberg, R.
    Frenkel, K. S.
    Kalickman, I.
    Barak, Vivian
    TUMOR BIOLOGY, 2006, 27 : 42 - 42
  • [46] Tebentafusp for the treatment of metastatic uveal melanoma
    Schank, Timo E.
    Hassel, Jessica C.
    FUTURE ONCOLOGY, 2022, 18 (11) : 1303 - 1311
  • [47] Prognostic value of legumain in uveal melanoma
    Wu, Tong
    Sun, Lei
    Wu, Ying
    Xiang, Rong
    Li, Yuwei
    Rong, Weining
    Sun, Fengyuan
    Wang, Ningli
    MOLECULAR MEDICINE REPORTS, 2016, 13 (03) : 2377 - 2384
  • [48] Validating prognostic models in metastatic uveal melanoma (MUM), an international rare cancers initiative
    Khoja, L.
    Atenafu, E.
    Joshua, A. M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma
    Lorenzo, Daniel
    Ochoa, Maria
    Maria Piulats, Josep
    Gutierrez, Cristina
    Arias, Luis
    Catala, Jaume
    Grau, Maria
    Penafiel, Judith
    Cobos, Estefania
    Garcia-Bru, Pere
    Javier Rubio, Marcos
    Padron-Perez, Noel
    Dias, Bruno
    Pera, Joan
    Maria Caminal, Josep
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1130 - 1139
  • [50] Novel prognostic markers for uveal melanoma
    Mascolo, Massimo
    Varricchio, Silvia
    Caltabiano, Rosario
    Tranfa, Fausto
    Strianese, Diego
    Ilardi, Gennaro
    Russo, Daniela
    De Rosa, Gaetano
    Staibano, Stefania
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S92 - S92